Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

    Virtual Booth

    Contact Supplier

    Coral

    Virtual Booth

    Contact Supplier

    ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    Virtual Booth

    Contact Supplier

    Menu

    Ateganosine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MAIA Bio Reveals Positive THIO-101 Phase 2 Data in Lung Cancer
    MAIA Bio Reveals Positive THIO-101 Phase 2 Data in Lung Cancer

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148625/0/en/MAIA-Biotechnology-Highlights-Positive-Efficacy-Data-from-THIO-101-Phase-2-Clinical-Trial-in-Non-Small-Cell-Lung-Cancer.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share
    MAIA Biotech's Abstract Chosen for Poster at IASLC Conference
    MAIA Biotech's Abstract Chosen for Poster at IASLC Conference

    05 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/05/3145282/0/en/MAIA-Biotechnology-Abstract-Selected-for-Poster-Presentation-at-2025-IASLC-World-Conference-on-Lung-Cancer.html

    GLOBENEWSWIRE
    05 Sep 2025
    Share Share
    FDA Fast Tracks MAIA Bio's Ateganosine for Lung Cancer
    FDA Fast Tracks MAIA Bio's Ateganosine for Lung Cancer

    28 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250728212094/en/MAIA-Biotechnology-Receives-FDAs-Fast-Track-Designation-for-Ateganosine-as-a-Treatment-for-Non-Small-Cell-Lung-Cancer

    BUSINESSWIRE
    28 Jul 2025
    Share Share
    MAIA Biotech CEO Outlines Cancer Immunotherapy Milestones in 2025
    MAIA Biotech CEO Outlines Cancer Immunotherapy Milestones in 2025

    01 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250401656979/en/MAIA-Biotechnology-CEO-Details-Anticipated-Clinical-Milestones-for-Novel-Cancer-Immunotherapy-in-2025-Letter-to-Shareholders

    BUSINESSWIRE
    01 Apr 2025
    Share Share